
a d powder 150gm upto 20% off sanjeevani pharma mumbai
Rated 5 out of 5 based on 1 customer rating
(1 customer review)
Save: 5%₹274.00 Original price was: ₹274.00.₹260.30Current price is: ₹260.30. inc. Tax
Highlights
a d powder 150gm upto 20% off sanjeevani pharma mumbai
buy more get more
5% off on single piece
10% off on 3 piece
15% off on 6 piece
20% off on 9 piece
international shipping available via DHL and INDIAPOST contact 8983023033

Worldwide shipping offered
76 in stock
About Product
Description
Description
Indication :
Diabetes mellitus
NIDDM – newly detected cases
In case where oral hypoglycemic agents develop resistance
As an adjuvant to insulin therapy and OHAS
get more information about this product on
Additional information
Additional information
Weight | 100 g |
---|---|
Brand |
Reviews (1)
Reviews (1)
5
Rated 5 out of 5
1 review
Rated 5 out of 5
1
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
1 review for a d powder 150gm upto 20% off sanjeevani pharma mumbai
Clear filters
Add a review Cancel reply
You must be logged in to post a review.
Best Before
Expires in between 6 Months to 2 Years from Today
our courier partner
Customer review
5
Rated 5 out of 5
1 review
Rated 5 out of 5
1
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
1 review for a d powder 150gm upto 20% off sanjeevani pharma mumbai
Clear filters
Add a review Cancel reply
You must be logged in to post a review.
Reviews (1)
Reviews (1)
5
Rated 5 out of 5
1 review
Rated 5 out of 5
1
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
1 review for a d powder 150gm upto 20% off sanjeevani pharma mumbai
Clear filters
Add a review Cancel reply
You must be logged in to post a review.
Related Products
D-B-T tab 600tab upto 10% off sharangdhar best buy
Rated 0 out of 5
Save: 5%
jambhulbeej ghana 500tab upto 20% off free shipping chaitanya pharmaceuticals
Rated 0 out of 5
₹1,000.00 inc. Tax
prakash –
Diabetes mellitusNIDDM – newly detected casesIn case where oral hypoglycemic agents develop resistanceAs an adjuvant to insulin therapy and OHAS